A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Clinical trial NCT07325526 · RECRUITING
Trial details
- NCT number
- NCT07325526
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2027-06-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.